ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2173

Role of Natural Killer Cells and Gamma Delta T Cells in Enthesitis Related Arthritis Category of Juvenile Idiopathic Arthritis

Priyanka Gaur1, Ramnath Misra2 and Amita Aggarwal2, 1Department of Clinical Immunology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India, 2Clinical Immunology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: innate immunity, juvenile idiopathic arthritis (JIA) and natural killer (NK) cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Innate Immunity and Rheumatic Disease: Mediators, Cells and Receptors

Session Type: Abstract Submissions (ACR)

Background/Purpose:  Enthesitis Related Arthritis (ERA) is the most common form of Juvenile Idiopathic Arthritis (JIA) in India. ERA is associated with increased frequency of Th17 cells and synovial fluid (SF) IL-17 levels. Recently innate immune cells like Natural Killer (NK) cells, γδ T cells have been reported to produce IL-17 and contribute to disease pathogenesis in Ankylosing spondylitis. Thus we have studied the frequency and effector functions of innate cells in ERA.

Methods: Fifty JIA-ERA, 21 other JIA patients (disease controls) and 25 healthy controls were enrolled in the study and peripheral blood (PB) was collected.19 paired synovial fluids were also studied. Frequency of NK cells, NKT cells, γδ T cells, expression of perforin in NK cells and KIR3DL1/2 on NK cell and T cells were measured by flow cytometry. Frequency of IL-17 producing T cells, NK cells and γδ T cells were quantified by Flow cytometry.

Results: Patients with ERA as compared with healthy controls had normal frequency of NK cells (9.52% ± 4.67 v/s 9.62% ± 2.65) and NKT cells (2.93% ± 1.96 v/s 2.42% ± 1.78) but had increased frequency of γδ T cells (9.31% ± 4.61 v/s 5.12% ± 2.61; p<0.001). Further NK cells in ERA patients had low expression of perforin (56.19% ± 15.67) and high KIR3DL1/2 expression (31.33% ± 12.13) as compared to controls (82.79% ± 9.43; p < 0.001, 21.32% ± 11.05, p=0.001 respectively). Frequency of IL-17 producing NK cells were increased in PB of JIA-ERA patients (n=10, 3.69% ± 2.72) as compared to healthy controls (n= 6, 0.83% ± 0.80; p = 0.01). Also the IL-17 producing γδ T cells were high in JIA-ERA (2.22% ± 2.20) than healthy controls (0.35% ± 0.56, p=0.02). In paired samples the frequencies of these cells were similar but as compared to PB,SF NK cells had reduced expression of perforin (56.64% ± 17.08 v/s 1.55% ± 2.5, p=0.001)and KIR3DL (31.39 ± 9.66 v/s 10.89% ± 10.84, p < 0.001).

 Conclusion: NK cells in ERA patients have CD56 bright phenotype with low perforin expression suggestive of cytokine producing cells. Further increase in KIR3DL1/2 expression on NK cells suggests that they may interact with HLA B27 and have enhanced survival. Increased frequency of IL-17 producing NK cells and γδ T cells in ERA suggests that in addition to Th17 cells they may also contribute to IL-17 in ERA.


Disclosure:

P. Gaur,
None;

R. Misra,
None;

A. Aggarwal,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/role-of-natural-killer-cells-and-gamma-delta-t-cells-in-enthesitis-related-arthritis-category-of-juvenile-idiopathic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology